Available to sourceHuman Prescription DrugGastrointestinal

PHOXILLUM

Active ingredients · Magnesium Chloride, Potassium Chloride, Sodium Bicarbonate, Sodium Chloride, Sodium Phosphate Dibasic

3.05 g/L / .314 g/L / 2.21 g/L / 6.95 g/L / .187 g/L · Injection

By Vantive US Healthcare LLC

NDC: 24571-117
Route: Intravenous
Therapeutic class: Calculi Dissolution Agent , Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative , Osmotic Laxative , Osmotic Laxative , Osmotic Laxative , Potassium Compounds [CS], Potassium Salt , Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
Marketing category: NDA

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.